These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20976566)

  • 1. Multiple stable periodic oscillations in a mathematical model of CTL response to HTLV-I infection.
    Li MY; Shu H
    Bull Math Biol; 2011 Aug; 73(8):1774-93. PubMed ID: 20976566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable and transient periodic oscillations in a mathematical model for CTL response to HTLV-I infection.
    Lang J; Li MY
    J Math Biol; 2012 Jul; 65(1):181-99. PubMed ID: 21792554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to HTLV-1.
    Bangham CR; Osame M
    Oncogene; 2005 Sep; 24(39):6035-46. PubMed ID: 16155610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is human T-cell lymphotropic virus type I really silent?
    Asquith B; Hanon E; Taylor GP; Bangham CR
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1013-9. PubMed ID: 11186302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of HTLV-I and the CTL response.
    Wodarz D; Nowak MA; Bangham CR
    Immunol Today; 1999 May; 20(5):220-7. PubMed ID: 10322301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
    Kuo CW; Mirsaliotis A; Brighty DW
    J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
    Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
    Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection.
    Asquith B; Bangham CR
    J Theor Biol; 2000 Nov; 207(1):65-79. PubMed ID: 11027480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low viral persistence of an immunological model.
    Ma S
    Math Biosci Eng; 2012 Oct; 9(4):809-17. PubMed ID: 23311423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenetic significance of HTLV-I infection and immune surveillance in HAM].
    Fujihara K
    Rinsho Shinkeigaku; 1999 Jan; 39(1):21-3. PubMed ID: 10377790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-I infection: a dynamic struggle between viral persistence and host immunity.
    Lim AG; Maini PK
    J Theor Biol; 2014 Jul; 352():92-108. PubMed ID: 24583256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
    Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
    J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.
    Altes HK; Wodarz D; Jansen VA
    J Theor Biol; 2002 Feb; 214(4):633-46. PubMed ID: 11851372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
    Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
    Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
    Tanaka Y; Tozawa H; Koyanagi Y; Shida H
    J Immunol; 1990 Jun; 144(11):4202-11. PubMed ID: 2187927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the T-cell dynamics and pathogenesis of HTLV-I infection.
    Stilianakis NI; Seydel J
    Bull Math Biol; 1999 Sep; 61(5):935-47. PubMed ID: 17886750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mathematical model of HTLV-I infection with two time delays.
    Lu X; Hui L; Liu S; Li J
    Math Biosci Eng; 2015 Jun; 12(3):431-49. PubMed ID: 25811549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune recognition of human T-cell leukemia virus type-I (HTLV-I) by MHC-restricted cytotoxic T lymphocytes.
    Tanaka Y
    Kitasato Arch Exp Med; 1992 Sep; 65(2-3):79-85. PubMed ID: 1308259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
    Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
    J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.